Tvardi Therapeutics's total assets for Q3 2025 were $39.02M, a decrease of -10.81% from the previous quarter. TVRD total liabilities were $11.15M for the fiscal quarter, a 3.07% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.